CLINICAL_TRIALS
trial_result
· 2018-04-20
Clinical Trial Update: A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department [Phase 4]
Summary
Phase 4 trial evaluating rivaroxaban for early discharge of low-risk pulmonary embolism patients from the emergency department, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Scientific Affairs, LLC | Conditions: Pulmonary Embolism | Phase 4 | Status: COMPLETED | Results posted: 2018-04-20